Depersonalization disorder may be related to glutamate receptor activation imbalance.
Andreas Pikwer
Medical Hypotheses October 2011 DOI: 10.1016/j.mehy.2011.06.041 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Key points | The author speculates that depersonalization disorder involves increased prefrontal cortex glutamate activity from an intrinsic imbalance, producing long-term potentiation at postsynaptic glutamate receptors on GABAergic interneurons, while the same receptor abnormality at amygdala intercalated GABAergic cells produces long-term depression. The author also notes that lamotrigine does not appear useful for treating depersonalization disorder, despite reducing some ketamine-induced dissociative effects. |
Abstract
Low-dose ketamine administration mimics, both clinically and on gross neuroimaging, depersonalization disorder. The perceptual effects of ketamine may be due to secondary stimulation of glutamate release and lamotrigine, possibly by inhibited glutamate release, may reduce some of ketamine's so-called dissociative effects. However, lamotrigine does not seem to be useful in the treatment of depersonalization disorder. Glutamate release in prefrontal cortex is increased by subanaesthetic doses of ketamine, resulting in increased inhibition, possibly via intercalated GABAerg cells, of projections from amygdala, affecting structures critically involved in depersonalization. I speculate that, in depersonalization disorder, the increased glutamate activity in prefrontal cortex is due to intrinsic imbalance, resulting in long-term potentiation, at the postsynaptic glutamate receptors on the GABAerg interneurons while the same receptor abnormality at the synapses on the intercalated GABAerg cells of the amygdala result in long-term depression in the case of either normal or high glutamate release.
Citations in the library
Cited by 2
Cites 5
- Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans Archives of General Psychiatry March 1, 1994
- Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex Journal of Neuroscience April 15, 1997
- Attenuation of the Neuropsychiatric Effects of Ketamine With Lamotrigine Archives of General Psychiatry March 1, 2000
- Glutamate and post-traumatic stress disorder: toward a psychobiology of dissociation. October 1, 1999
- Psychological effects of ketamine in healthy volunteers. Phenomenological study. The British Journal of Psychiatry August 1, 2006